Compare Dow Inc (DOW) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dow Inc vs Novo Nordisk A/S — how do they compare? Dow Inc trades at $29.65 (market cap $21.85B), while Novo Nordisk A/S trades at $50.94 (market cap $214.94B). The key difference: Novo Nordisk A/S is far larger — about 9.8× Dow Inc's market cap, and Dow Inc pays the higher dividend (4.62%). Which is the better fit depends on your goals.
| DOW | NVO | |
|---|---|---|
Market Cap | $21.85B | $214.94B |
Sector | Basic Materials | Health |
52-Week High | $41.87 | $71.70 |
52-Week Low | $20.65 | $35.29 |
Enterprise Value | $37.62B | $233.91B |
Dividend Yield | 4.62% | 3.67% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
